Biopharmaceuticals

Substrate placeholder — needs review

Outlook Therapeutics Announces $5 Million Registered Direct Offering

Outlook Therapeutics has announced a $5 million registered direct offering priced at $0.31 per share, including warrants. The offering is expected to close on April 23, 2026. This move provides the company with additional capital through a direct sale of securities.

2 sources